期刊文献+

PRL腺瘤的侵袭性相关因素分析

The analysis of factors relative to the invasiveness in patients with Prolatinomas
下载PDF
导出
摘要 目的:评估垂体PRL腺瘤的侵袭性与术前血清PRL、肿瘤大小、性别、年龄的关系,为PRL腺瘤患者制定进一步治疗方案提供依据。材料和方法:收集并综合分析昆医附一院首次住院治疗且资料完整的33例泌乳素(PRL)腺瘤患者的临床资料,分别检测术前血清PRL水平,分析患者的年龄组成、性别差异,测量磁共振(MR I)影像上肿瘤大小,按照W ilson改良Hardy分类方法判断肿瘤侵袭性。结果:本组资料中33例PRL腺瘤患者,侵袭性腺瘤12例,非侵袭性腺瘤21例;男性8例,女性25例。Logistic回归分析:较大腺瘤发生侵袭的可能性是较小腺瘤的1.435倍;女性PRL腺瘤患者肿瘤发生侵袭的可能性是男性的12.5%。侵袭性与非侵袭性PRL腺瘤的大小、性别比较差异均有统计学意义(P=0.000,P=0.015)。结论:肿瘤的侵袭性与肿瘤大小、性别相关,与术前PRL水平、年龄无关。 Objective: To assess the relationships between preoperative PRL levels, tumor size, gender, age and tumor invasiveness of Prolactinomas and provide evidences on further therapeutic strategies for patients with Prolactinomas. Materials and Meth- ods: We collected and analyzed 33 initial treated cases of patients with prolactin (PRL) adenomas of our department with complete data. All patients were tested preoperative PILL, analyzed age composition, gender differences and the tumor size of MRI. The invasiveness of pituitary adenomas were judged according to Hardy's classification scheme modified by Wilson. Result: There were 33 patients with PRL - secreting pituitary adenomas, 8 males and 25 females, 12 patients with invasive adenomas and 21 patients with noninvasive adenomas. Logistic regression analysis indicated that the incidence of invasive adenomas in patients with a larger tumor is 1. 435 times higher than that of patients with a smaller tumor. The occurrence rate of invasive adenomas in women is 12. 5% of men. The size and gender of invasive adenomas and the size of non - invasive adenomas was statistically significant ( P = 0. 000, P = 0. 015 ). Conclusion: The invasion of tumor was closely related to the size and gender, not to the preoperative PRL levels and age.
出处 《中国民族民间医药》 2011年第16期22-23,25,共3页 Chinese Journal of Ethnomedicine and Ethnopharmacy
关键词 泌乳素腺瘤 泌乳素 侵袭性 Invasiveness prolactinoma prolactin
  • 相关文献

参考文献7

  • 1Shrivastava RK, Arginteanu MS, King WA, Post KD. Giant prolactinomas : clinical management and long -term follow up. J Neurosurg, 2002 Aug, 97 (2) : 299 - 306.
  • 2Delgmnge E, Sassolas G, Parrin Get al. Clinical and histological correlations in prolactinomas, with special reference to bromocrlptine resistance. Acta Nettrochir (Wien). 2005 Jul, 147 (7): 751-7; discussion 757-8. Epub 2005 Mar 14.
  • 3Pichon MF, Bression D, Peillon F, et al. Estrogen receptors in human pituitary adenoma. J Clin Endocrinol Metab, 1980 Oct, 51 (4) : 897 -902.
  • 4Jafrain - Rea ML, Petrangeli E, Ortolani F, et al. Cellular receptors for sex sterids in human pituitary adenomas. J Endorinol, 1996 Nov, 151 (2) : 175 -84.
  • 5Stefaneanu L, Kovacs K, Scheithauer BW et al. Effect of Dopamine Agonists on Lactotroph Adenomas of the Human Pituitary. Endecr Pathol, 2000 Winter, 11 (4): 341-352.
  • 6崔友强,汪建军,滕良珠,孔建新,李猛,郭建,孙金龙.泌乳素腺瘤ER、PTTG、PCNA的表达与肿瘤侵袭性的关系[J].中国实用神经疾病杂志,2009,12(5):1-4. 被引量:4
  • 7Burdman JA, Pauni M, Heredia Sereno GM, et al. Estrogen receptors in human pituitary tumors. Horm Metab Res, 2008 Aug, 40 (8) : 524 -7. Epub 2008 Apt 9.

二级参考文献11

  • 1魏新亭,李玉斌,宋来君.基质金属蛋白酶及其组织抑制因子在垂体腺瘤中的表达[J].中国实用神经疾病杂志,2007,10(1):15-17. 被引量:2
  • 2Burdman JA,Pauni M,Heredia Sereno GM,et al.Estrogen receptors in human pituitary tumors[J].Horm Metab Res,2008,40(8):524-527.
  • 3Kreutzer J,Fahlbusch R.Diagnosis and treatment of pituitary tumors[J].Current Opinion in Neurology,2004,17(6):693-703.
  • 4Yu R,Melmed S.Pituitary tumor transforming gene:an update[J].Front Horm Res,2004,32(2):175-185.
  • 5萨姆布鲁克J,费里奇EF,曼尼阿蒂斯J.分子克隆实验指南[M].第2版.北京:北京科学出版社,1995:889-898.
  • 6Talan-Hranilovic J,Gnjidic Z,Sajiko T,et al.Comparative immunohistochemical analysis of estrogen receptor and chromogranin-A reactivity in plurihormonal human prolactinomas[J].Acta Med Croatica,2000,54(1):59-63.
  • 7Pei L,Melmed S.Isolation and characterization of a pituitary tumor transformation gene (PTTG)[J].Molecular Endocringology,1997,11(10):433-441.
  • 8Zhang X,Horwitz G,Heaney A,et al.Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas[J].Clin Endocrinol Metab,1999,84(2):761-767.
  • 9Tella J,Herculano M,Delcelo R.Pituitary adenomas:relationship between invasiveness and proliferative cell nuclear index[J].Arq Neuropsiquiatr,2000,58(11):1055-1059.
  • 10李伟,傅震.垂体腺瘤中PCNA蛋白表达的研究[J].临床神经病学杂志,2001,14(3):136-137. 被引量:6

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部